Press Releases

Welcome to the Investing News Network's press release section, where you can stay informed with past and present announcements from our clients. Explore the latest stock news from mining, technology and life science companies and gain an investing edge by staying up to date with today's press releases.
Filters
Clear All Filters
Filter ✕

Date Range

Sector

BriaCell Therapeutics (BCT:CC)

BriaCell Opens First Canadian Site - Sunnybrook - for Pivotal Phase 3 Trial in Metastatic Breast Cancer

pharmaceutical investing
BriaCell Therapeutics (BCT:CC)

BriaCell Arranges Scalable Manufacturing with FUJIFILM Biotechnologies for Bria-IMT

pharmaceutical investing
BriaCell Therapeutics (BCT:CC)

BriaCell Engages Consulting and Branding Firms to Support Commercial and Market Access Evaluation of Bria-IMT

pharmaceutical investing

Government approvals secured for the use of Galidesivir as a treatment for Bundibugyo Ebola epidemic in Africa

Lexaria Bioscience (LEXX)

Lexaria Updates Business Development

biotech investing
Lexaria Bioscience (LEXX)

Lexaria Updates Business Development

biotech investing
Lexaria Bioscience (LEXX)

Lexaria's Human Study GLP-1-H26-7 Has Begun Dosing on Schedule

biotech investing
BriaCell Therapeutics (BCT:CC)

BriaCell Partners with Uneedle for Scalable Microneedle Administration of Bria-IMT

pharmaceutical investing
Lexaria Bioscience (LEXX)

Lexaria's Animal Study GLP-1-A26-1 Has Begun Dosing on Schedule

biotech investing
Lexaria Bioscience (LEXX)

GLP-1 "Arms Race" Intensifies as the Addressable Markets Continue to Expand

biotech investing
Lexaria Bioscience (LEXX)

GLP-1 'Arms Race' Intensifies as the Addressable Markets Continue to Expand

biotech investing
Lexaria Bioscience (LEXX)

Lexaria's Animal Study Examining Next-Generation GLP-1 drugs is Underway

biotech investing
Lexaria Bioscience (LEXX)

Lexaria's Animal Study Examining Next-Generation GLP-1 drugs is Underway.

biotech investing
Lexaria Bioscience (LEXX)

Lexaria Attending the BIO International Convention, as Part of a Broader Business Development Program

biotech investing
BriaCell Therapeutics (BCT:CC)

BriaCell Therapeutics Announces Closing of Offering

biotech investing
BriaCell Therapeutics (BCT:CC)

BriaCell Presents Positive Clinical Data at ASCO 2026

biotech investing
BriaCell Therapeutics (BCT:CC)

BriaCell Therapeutics Announces Pricing of Offering

biotech investing
BriaCell Therapeutics (BCT:CC)

BriaCell Receives Positive Recommendation from Data Safety Monitoring Board for Phase 3 Study in Metastatic Breast Cancer

biotech investing
BriaCell Therapeutics (BCT:CC)

BriaCell Presentations Highlight Positive Clinical Data for Bria-IMT at ASCO 2026

biotech investing
Lexaria Bioscience (LEXX)

Lexaria Receives Independent Review Board Approval to Begin Human Pilot Study #7

biotech investing

Latest News

More News

Outlook Reports

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES